GlassScriptPhysician profile
Arnold I Levin
NPI 1235199548
$7,157.29
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $400 · 2021: $5,257 · 2022: $1,057.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $5,245.42 | 2021-2022 | |
| Janssen Biotech, INC. | $719.91 | 2019-2022 | |
| Abbvie INC. | $335.94 | 2019-2022 | |
| Celgene Corporation | $219.26 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $122.67 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.68 | 2019-2022 | |
| Fujifilm Healthcare Americas Corporation | $98.91 | 2021 | |
| Boston Scientific Corporation | $87.74 | 2019 | |
| Nestle Healthcare Nutrition INC. | $64.36 | 2021-2022 | |
| Pfizer INC. | $29.55 | 2019-2022 | |
| Daiichi Sankyo INC. | $24.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.94 | 2021 | |
| Shire North American Group INC | $22.63 | 2019 | |
| Gilead Sciences, INC. | $17.97 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.09 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.08 | 2019 | |
| Braintree Laboratories, INC. | $12.47 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.